Head & Neck

ACR TI-RADS: Thyroid Ultrasound Is Triage, Not Cataloguing

Fellowship-level neuroradiology teaching by E. Brooke Schrickel, MD. Open this topic in the interactive reading room →

Watch · concise explainerVisual summary

Core clinical idea

Thyroid US is triage, not cataloguing: recognize the dismissible nodule patterns fast, point your scoring only at the few nodules that could change management, and report only those — the classic miss is treating TI-RADS as a describe-every-nodule obligation that buries the one needing FNA.

Bottom line

TI-RADS is a triage tool — dismiss the benign patterns fast, score only what could change management, and let clinical context override the points.

Core workstation questions

  • Has the whole gland been surveyed so I'm scoring the right targets, or just whatever appeared first?
  • Is this one of the dismissible patterns (TR1 cystic/spongiform, TR2 mixed iso/hyperechoic), and are its benign features actually clean?
  • For mixed nodules, am I judging echogenicity off the solid component? Is 'very hypoechoic' referenced to strap muscle?
  • Does clinical context (PET-avid, suspicious ipsilateral node, prior biopsy) push me off the standard recommendation?
  • Am I over-reporting — describing nodules that don't meet biopsy or follow-up criteria?

What changes reporting / management

  • Report only nodules meeting criteria for biopsy or follow-up; cap the report at the few most suspicious when many qualify.
  • A suspicious ipsilateral node or PET-avid nodule can warrant biopsy even when points alone wouldn't trigger it.
  • For a previously biopsied nodule, still score and give the TI-RADS recommendation but flag prior sampling.
  • A normal-appearing gland or non-qualifying nodules don't need the full template.

Practical traps

  • Treating TI-RADS as describe-every-nodule, wasting time and burying the actionable nodule.
  • Letting a cystic-appearing nodule with eccentric mural nodularity, punctate echogenic foci, or taller-than-wide shape pass as a dismissible 'good nodule'.
  • Judging echogenicity off the wrong reference (must be solid component for mixed nodules; very-hypoechoic is relative to strap muscle).
  • Calling a nodule spongiform without confirming absence of aggressive features.

Teaching pearls

  • You don't need to describe, score, or report every nodule — only the ones that change management.
  • Learn the dismissible patterns cold; that's where the time savings live.
  • Judge echogenicity off the right reference — solid component for mixed nodules, strap muscle for very-hypoechoic.
  • A suspicious node or PET avidity can override the TI-RADS score — biopsy on the clinical picture.

Teaching visuals

ACR TI-RADS as a TriageDecide whether a nodule is even worth scoring before you count pointsDRAFTSTEP 1 · TRIAGECan I dismissthis nodule?cystic / truly spongiformYESTR1 benign / TR2 not suspiciousNo FNA & no follow-upat any sizeDISMISSEDNOSTEP 2 · SCOREScore 5 categories → TR levelCompositionEchogenicityShapeMarginEchogenic fociSum points across all five → TR1 through TR5Higher total = higher TR level = higher suspicionTR1escalating riskTR5STEP 3 · ACT ON SIZESize thresholds (TR3–TR5)TRFNA if ≥Follow if ≥TR32.5 cm1.5 cmTR41.5 cm1.0 cmTR51.0 cm0.5 cmFNA = fine-needle aspiration; follow = US surveillanceReporting disciplineReport only nodules that meet FNA /follow-up criteria — don't catalogevery nodule.Per ACR white paper.
ACR TI-RADS as a Triage
TI-RADS Threshold CardWhen to aspirate vs when to surveil, by TR levelLEVELFNA if ≥FOLLOW if ≥TR1benign——TR2not suspicious——TR3mildly suspicious2.5 cm1.5 cmTR4moderately suspicious1.5 cm1.0 cmTR5highly suspicious1.0 cm0.5 cmFNA = fine-needle aspiration. — = neither FNA nor follow-up indicated, at any size.Per ACR white paper.
TI-RADS Threshold Card

Source lectures

  • ACR TI-RADS Overview and Approach

Educational material for radiology residents and neuroradiology fellows. Nothing here drives individual patient care, and it contains no patient data.